Trial site
Azienda Socio Sanitaria Territoriale Della Valle Olona
- 14running trials
- 1closed trial
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Follicular lymphoma3 trials
- Multiple sclerosis3 trials
- Acute myeloid leukaemia2 trials
- Childhood cancers1 trial
- Chronic kidney disease1 trial
- Chronic lymphocytic leukaemia1 trial
- Chronic myeloid leukaemia1 trial
- COPD1 trial
- Heart failure1 trial
- Hodgkin lymphoma1 trial
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- and 2 more
- Phase
- Phase 310 trials
- Phase 22 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Recruiting7 trials
- Active, not recruiting6 trials
- Completed1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Fondazione Italiana Linfomi - ETS2 trials
- Hoffmann-La Roche2 trials
- Alexion Pharmaceuticals Inc.1 trial
- AstraZeneca1 trial
- AstraZeneca AB1 trial
- and 8 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.
Recruiting
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
Recruiting
COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease
Recruiting
A Phase 1/2 study of Enzomenib (DSP-5336) in Patients with Acute leukemia
Active, not recruiting
Active, not recruiting
Clinical study testing the efficacy and safety of Ravulizumab in pediatric patients with NMOSD
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia2 recruiting
- Childhood cancers1 recruiting
- Chronic kidney disease1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Chronic myeloid leukaemia1 recruiting
- COPD1 recruiting
- Follicular lymphoma1 recruiting
- Heart failure1 recruiting
- Hodgkin lymphoma1 recruiting
- Metastatic breast cancer1 recruiting
- Myelodysplastic syndromes1 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026